Outcome of Radiation Therapy in Operated Gastric Cancer

Outcome of Radiation Therapy In Operated Gastric Cancer

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04810663

Enrollment

Registered

2021-03-23

Start date

2021-04-01

Completion date

2023-04-01

Last updated

2021-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Adenocarcinoma

Brief summary

* Study tolerability and toxicity of radiotherapy with or without chemotherapy for operated gastric cancer. * Evaluate the efficacy of adjuvant radiotherapy with or without chemotherapy as regarding local control and overall survival.

Interventions

RADIATIONRadiotherapy

Adjuvant Radiotherapy in operated gastric cancer

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* Age of the patient; ≥18 and ≤75 years. * Histologically proven gastric or gastroesophageal adenocarcinoma. * Pt received adjuvant Radiotherapy with or without chemotherapy with any protocol.

Exclusion criteria

* Patient \>75 years&\<18 years. * Histologically types other than adenocarcinoma . * Metastatic patients (M1). * Pt didn't recive radiotherapy.

Design outcomes

Primary

Measure	Time frame	Description
Efficacy of Radiotherapy in operated gastric cancer	Baseline	Disease Free Survival

Contacts

Primary ContactMohamed Ahmed Ezzat, Master degree

maezzatma9@gmail.com+201068490648

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026